ANTARES PHARMA, INC. Insider Trading for January 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for January 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 17 2014 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Option Exercise | M | 0.50 | 22,900 | 11,450 | 1,417,483 | |
Jan 17 2014 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Sell | S | 5.10 | 22,900 | 116,758 | 708,734 | 731.6 K to 708.7 K (-3.13 %) |
Jan 17 2014 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Buy | M | 0.50 | 22,900 | 11,450 | 731,634 | 708.7 K to 731.6 K (+3.23 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.40 | 1,250 | 1,750 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 0.70 | 1,250 | 875 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 0.90 | 2,000 | 1,800 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 0.95 | 500 | 475 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.01 | 2,000 | 2,020 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.32 | 500 | 660 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.40 | 2,000 | 2,800 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.10 | 2,000 | 2,200 | 0 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.40 | 1,250 | 1,750 | 8,986,413 | 9 M to 9 M (+0.01 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 0.70 | 1,250 | 875 | 8,985,163 | 9 M to 9 M (+0.01 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 0.90 | 2,000 | 1,800 | 8,983,913 | 9 M to 9 M (+0.02 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 0.95 | 500 | 475 | 8,981,913 | 9 M to 9 M (+0.01 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.01 | 2,000 | 2,020 | 8,981,413 | 9 M to 9 M (+0.02 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.32 | 500 | 660 | 8,979,413 | 9 M to 9 M (+0.01 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.40 | 2,000 | 2,800 | 8,978,913 | 9 M to 9 M (+0.02 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.10 | 2,000 | 2,200 | 8,976,913 | 9 M to 9 M (+0.02 %) |
Jan 17 2014 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 0.50 | 11,400 | 5,700 | 624,847 | |
Jan 17 2014 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 5.05 | 11,400 | 57,571 | 126,829 | 138.2 K to 126.8 K (-8.25 %) |
Jan 17 2014 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 0.50 | 11,400 | 5,700 | 138,229 | 126.8 K to 138.2 K (+8.99 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 10,000 | 4,700 | 1,113,682 | |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 5.00 | 10,000 | 50,000 | 368,918 | 378.9 K to 368.9 K (-2.64 %) |
Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 10,000 | 4,700 | 378,918 | 368.9 K to 378.9 K (+2.71 %) |